Compare Novavax Inc (NVAX) vs Sea Limited (SE) Price & Performance

Novavax IncTrade

Sea LimitedTrade

Price performance (Past 24H)

Key statistics

Novavax Inc vs Sea Limited — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Sea Limited trades at $106.26 (market cap $64.73B). The key difference: Sea Limited is far larger — about 49.8× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Sea Limited nearer its low. Which is the better fit depends on your goals.

	NVAX	SE
Market Cap	$1.30B	$64.73B
Sector	Health	Media
52-Week High	$11.19	$196.50
52-Week Low	$6.22	$78.16
Enterprise Value	$800.50M	$57.78B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVAX

View details →

Sea Limited stock drops 32% despite stronger fundamentals, seen as market disconnect by analystSeeking Alpha · 16 hours agoBullish Sea Limited posts $7B revenue and $1B EBITDA in Q1 2026, showing strong growth and profitability.Seeking Alpha · 4 days agoBullish View details →

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

About Sea Limited

Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.